Infusion therapy comprises the usage of needles and catheters to inject medication into a patient’s body, in contrast to administering the medicine orally. Some conditions require infusion therapy, since oral doses have no effect on the ailment. Home infusion therapy can be administered by the patient or a healthcare dispenser at the convenience of the patient. This allows for precise doses of medication to be delivered without the patient having to visit the physician’s office, since the infusion therapy equipment is prescribed by a physician.
Perceive the Complete Market Structure of Home Infusion Therapy at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1702
Home infusion therapy is usually used to administer insulin, painkillers, antibiotics, parenteral nutrition, and IVIG therapy. Among these, insulin home infusion procedures constitute the most commonly employed type of home infusion therapy, followed by painkillers and IVIG. Most home infusion therapies are administered intravenously, though some may also be delivered via tubes placed in the patient’s abdomen.
The rising prevalence of diabetes around the world thus acts as a major driver of the global home infusion therapy market. Lifestyle changes around the world and the consequent changes brought about in the diet of the global populace has led to rising prevalence of diabetes, which requires regular administration of insulin. Since it can be inconvenient for patients to visit the physician’s office every time they need an insulin shot, home infusion therapy is quickly picking up speed in the developed world.
The home infusion therapy market is also driven by the reduction they bring about in the duration of hospital stays. Since patients can use home infusion therapy products in the comfort of their own home, hospital costs are reduced drastically. However, the risk of inaccurate administration or administration of an overdose by a patient has restricted the global home infusion therapy market so far.
Major players in the global home infusion therapy market are analyzed in the report and their performance over the past few years is examined to provide projections for their future growth. Key companies in the home infusion therapy market include Stryker Corporation, Bristol-Myers Squibb, Abbott Laboratories, and Eli Lilly and Company.